Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study

INTRODUCTION: Many commercially available glucagon products for treatment of severe hypoglycaemia require cumbersome reconstitution and potentially intimidating injection during an emergency. Nasal glucagon (NG) is a novel drug-device combination product consisting of a single-use dosing device that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Ther
Main Authors: Suico, Jeffrey G., Hövelmann, Ulrike, Zhang, Shuyu, Shen, Tong, Bergman, Brandon, Sherr, Jennifer, Zijlstra, Eric, Frier, Brian M., Plum-Mörschel, Leona
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7324463/
https://ncbi.nlm.nih.gov/pubmed/32514794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00845-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados